Pfizer Inc. (PFE)
Last updated: 2026-11-06 02:49:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Pfizer Inc. (PFE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $29.89, with a market capitalization of $170.99B and a P/E ratio of 39.47. Over the past 52 weeks, its price has ranged from $23.62 to $31.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$170.99B | |
$31.09 | |
$61.71 | |
$11.62 | |
$30.79 | |
40.88M | |
33.54M | |
39.47 | |
$31.44 | |
$23.62 | |
5.72% | |
2001-12-30 |
Pfizer Inc. (PFE) Latest Closing Stock Price
Pfizer Inc. (PFE) last closed at $30.79 as of 2026-11-06 00:57:49, unchanged from the previous close of $30.79.
During the latest regular trading session, PFE traded between $11.62 and $61.71, with a volume of 40.88M shares. The closing price was near the middle and near the upper end of its 52-week range.
Pfizer Inc. (PFE) 7-Day Stock Price Change
Over the past seven days, Pfizer Inc. (PFE) moved from $29.80 to $29.89, representing a gain of 0.29% ($0.09).
The stock traded between $29.22 and $31.44 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 40.91 million shares, up versus the previous seven-day period, indicating higher trading activity.
PFE 52-Week Price Position
Position in Range: 80.2%
PFE is currently trading at $29.89, placing it 80.2% of the way from its 52-week low of $23.62 to its 52-week high of $31.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Pfizer Inc. (PFE)?
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75000 |
| CEO | Albert Bourla |
| Founded | 1849 |
| Exchange | NYSE |
| Company Website |
How to Buy Pfizer Inc. (PFE) Stock on MEXC
Eligible investors can buy real shares of Pfizer Inc. (PFE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Pfizer Inc. (PFE) stock price today?
2.Is PFE stock going up or down today?
3.What is PFE pre-market price?
4.What is PFE after-hours price?
5.Is PFE stock trading now?
6.Where does PFE sit relative to its 52-week high and low?
7.What sector is Pfizer Inc. in?
8.What is Pfizer Inc.'s market capitalization and where is it listed?
9.How is PFE valued in terms of P/E ratio and EPS?
10.Does Pfizer Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PFE Stock Calculator
Estimate the value between PFE shares and USD.
PFE Shares to USD
1.00 PFE shares = 29.886 USD
Calculations are estimates based on the latest available price and are for reference only.


